Affichage 1 à 10 des 11 essais cliniques
1 | 2 |
1 |
2 |
1 | 2 |
|
ESSAIS CLINIQUES No essai ClinicalTrials.gov ID |
Phase | Coordonnateur(rice) | |
|---|---|---|---|
|
(EN) Capturing Canadian Real-World Data for AML Chemotherapy Ineligible Patients on Venetoclax
LIVEN (P23-363) NCT05424562  Actif en recrutement
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL SITE GLEN |
Judit Kokai 438-888-1582 |
|
|
Banque des cellules leucémique du Québec
banque cellules leucémique Actif en recrutement
|
CHU DE QUEBEC – UNIVERSITE LAVAL L'HOTEL-DIEU DE QUEBEC ET CRCEO |
Marie-Pierre Brochu 418-525-4444 poste 15768 |
|
|
(EN) A Phase 1/2 First in Human Study of the Menin-MLL(KMT2A) Inhibitor KO-539 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
KO-MEN-001 NCT04067336 Actif en recrutement
|
CHU DE QUEBEC – UNIVERSITE LAVAL HOPITAL DE L'ENFANT-JESUS |
Philippe Nadeau 418-649-0252 poste 63115 |
|
|
Banque des cellules leucémique du Québec
banque cellules leucémique Actif en recrutement
|
CHU DE QUEBEC – UNIVERSITE LAVAL HOPITAL DE L'ENFANT-JESUS |
Linda Vallée 418-649-0252 poste 66602 |
|
|
(EN) A Phase 1/2 First in Human Study of the Menin-MLL(KMT2A) Inhibitor KO-539 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
KO-MEN-001 NCT04067336 Actif en recrutement
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX |
Julie Trinh Lu 514-252-3400 poste 3336 |
|
|
(EN) A Randomized, Open Label Phase 3 Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine After Allogeneic Stem Cell Transplantation in Subjects With Acute Myeloid Leukemia
VIALE-T NCT04161885 Actif en recrutement
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL SITE GLEN |
Judit Kokai 438-888-1582 |
|
|
(EN) A Single-Arm, Open-Label Pharmacokinetic, Safety, and Efficacy Study of ASTX727 in Combination With Venetoclax in Adult Patients With Acute Myeloid Leukemia
ASTX727-07 NCT04657081 Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Aline Khayat 514-340-8222 |
|
|
(EN) An Open-Label Phase 1a/1b Dose Escalation and Expansion Cohort Study of SL-172154 (SIRP?-Fc-CD40L) in Combination With Azacitidine or With Azacitidine and Venetoclax for the Treatment of Subjects With Higher-Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
SL03-OHD-104 NCT05275439 Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Maria Kluchnyk 514-340-8222 poste 26394 |
|
|
(EN) A Phase 1 Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
LOXO-IDH-20001 NCT04603001 Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
||
|
(EN) A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Newly Diagnosed, Previously Untreated Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy
ENHANCE-3 NCT05079230 Actif en recrutement
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX |
Julie Trinh Lu 514-252-3400 poste 3336 |
Groupe d'étude en oncologie du Québec